Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Therapeutics Initiates Rolling NDA Submission To FDA For Emcitate

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    19/12/2025 06:04
    Dec 19 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

INITIATES ROLLING NDA SUBMISSION TO FDA FOR EMCITATE

PLANS NDA COMPLETION EARLY 2026, FDA APPROVAL Q3 2026

Source text: ID:nMFNb8lb1t

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news